(Q48117450)

English

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24332238

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial. (English)

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24332238

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David Cunningham

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jane M. Blazeby

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Srinivasan Madhusudan

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Hugo E R Ford

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Andrea Marshall

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

John A Bridgewater

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Tobias Janowitz

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Fareeda Y Coxon

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jonathan Wadsley

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Wasat Mansoor

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

David Fyfe

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Daniel Swinson

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Stephen Falk

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Ian Chau

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Paula Kareclas

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Janet A Dunn

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

COUGAR-02 Investigators

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

10 December 2013

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/24332238

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

78-86

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24332238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of messy longitudinal data from a randomized clinical trial. MRC Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous analysis of quality of life and survival data.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 400

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Race and ethnicity correlate with survival in patients with gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Communicating quality of life information to cancer patients: a study of six presentation formats.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970549-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48117450&oldid=1577710528"